- Home
- ADAG vs CBAT Comparison
ADAG vs CBAT Comparison
Compare ADAG & CBAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADAG
- CBAT
- Stock Information
- Founded
- ADAG 2011
- CBAT 1999
- Country
- ADAG China
- CBAT China
- Employees
- ADAG N/A
- CBAT N/A
- Industry
- ADAG Biotechnology: Pharmaceutical Preparations
- CBAT Industrial Machinery/Components
- Sector
- ADAG Health Care
- CBAT Miscellaneous
- Exchange
- ADAG Nasdaq
- CBAT Nasdaq
- Market Cap
- ADAG 84.4M
- CBAT 90.4M
- IPO Year
- ADAG 2021
- CBAT N/A
- Fundamental
- Price
- ADAG $1.88
- CBAT $0.90
- Analyst Decision
- ADAG Strong Buy
- CBAT
- Analyst Count
- ADAG 3
- CBAT 0
- Target Price
- ADAG $7.67
- CBAT N/A
- AVG Volume (30 Days)
- ADAG 82.0K
- CBAT 200.5K
- Earning Date
- ADAG 08-12-2025
- CBAT 11-10-2025
- Dividend Yield
- ADAG N/A
- CBAT N/A
- EPS Growth
- ADAG N/A
- CBAT N/A
- EPS
- ADAG N/A
- CBAT N/A
- Revenue
- ADAG $103,204.00
- CBAT $145,462,366.00
- Revenue This Year
- ADAG $7,411.34
- CBAT N/A
- Revenue Next Year
- ADAG $28.29
- CBAT $60.02
- P/E Ratio
- ADAG N/A
- CBAT N/A
- Revenue Growth
- ADAG N/A
- CBAT N/A
- 52 Week Low
- ADAG $1.30
- CBAT $0.57
- 52 Week High
- ADAG $3.16
- CBAT $1.28
- Technical
- Relative Strength Index (RSI)
- ADAG 53.39
- CBAT 42.84
- Support Level
- ADAG $1.44
- CBAT $0.89
- Resistance Level
- ADAG $1.96
- CBAT $0.95
- Average True Range (ATR)
- ADAG 0.19
- CBAT 0.04
- MACD
- ADAG 0.02
- CBAT -0.00
- Stochastic Oscillator
- ADAG 71.12
- CBAT 27.02
About ADAG Adagene Inc.
Adagene Inc is a platform-driven, clinical-stage biopharmaceutical company engaged in transforming the discovery and development of novel antibody-based cancer immunotherapies. It is principally engaged in research, development, and production of monoclonal antibody drugs for cancers. The company's platform is designed to generate therapeutic antibody candidates with functional epitopes and species cross-reactivity, as highlighted by the company's immunotherapy pipeline.
About CBAT CBAK Energy Technology Inc.
CBAK Energy Technology Inc is engaged in the manufacture, commercialization, and distribution of a variety of standard and customized lithium and sodium high-power rechargeable batteries. The batteries are used in light electric vehicles, electric vehicles, energy storage devices, and other high-power applications. The company has two operating segments: CBAK, which derives maximum revenue, and includes the manufacturing, commercialization, and distribution of various standard and customized lithium-ion rechargeable batteries; and the Hitrans segment, which includes the development and manufacturing of NCM precursor and cathode materials. Geographically, the company derives its key revenue from Mainland China, followed by Europe and other regions.